Neomycin Sulfate: adverse event reports in all combinations
Active ingredient, alone and in combinations
Brand names with this ingredient: Neo-Cortef, Neo-Delta-Cortef with Tetracaine, Biosol, Panolog, Jenomycin, Neo-synalar, and 22 more.
The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.
Read this first. FDA says this about the data:
An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another. When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event. This dataset should not be the sole source of information for clinical decision-making or other assumptions about the safety or effectiveness of a product. The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.
FDA Center for Veterinary Medicine publishes these words. Source: Adverse Event Reports for Animal Drugs and Devices, read on . The data have the reports that FDA received through .
This page is not veterinary advice. For an animal that is ill, speak to a veterinarian.
Contacting a veterinarianHow to report to FDAFDA reports received through . Counts include this ingredient alone and in combinations. Why brand names have no separate count.
From September 1988 to June 2026, FDA received 2,653 adverse event reports that name a drug with neomycin sulfate, alone or in a combination. 8 sets of active ingredients with neomycin sulfate have a drug page.
Of the 2,653 reports, 1,435 (54.1%) are about dogs. 813 reports are about cats (30.6%). In January to March 2026, FDA received 112 reports that name neomycin sulfate, alone or in a combination. The signs that appear in the largest number of the 2,653 reports are "Deafness", "Lethargy" and "Vomiting". A report is not proof that a drug caused a sign.
Reports that name this ingredient rose by 31.5% in the 12 months to June 2026, compared with the 12 months before. Reports for all animal drugs fell by 4.6% in the same periods. The newest months can get more reports in a later update. Reports about cats are 30.6% of the reports that name this ingredient, and 11% of all reports.
Reports in the latest closed quarter
| Species | Jan to Mar 2026 | Oct to Dec 2025 | Jan to Mar 2025 |
|---|---|---|---|
| All species | 112 | 113 | 57 |
| Dog | 37 | 52 | 27 |
| Cat | 49 | 53 | 23 |
| Horse | 0 | 0 | 0 |
| Other or not given | 26 | 8 | 7 |
January to March 2026 is the latest closed quarter in the data.
Drug pages with neomycin sulfate
A report names a drug by its set of active ingredients. Each set with neomycin sulfate that has a drug page is in the table, in order of name. The table has 8 sets.
| Active ingredients | Reports, all years | Reports, latest 12 months |
|---|---|---|
| Dexamethasone + Neomycin Sulfate + Polymyxin B Sulfate | 32 | 7 |
| Dexamethasone + Neomycin Sulfate + Thiabendazole | 1,137 | 174 |
| Isoflupredone Acetate + Neomycin Sulfate + Tetracaine Hydrochloride | 126 | 8 |
| Neomycin Sulfate | 34 | 1 |
| Neomycin Sulfate + Nystatin | 100 | 0 |
| Neomycin Sulfate + Nystatin + Thiostrepton | 63 | 1 |
| Neomycin Sulfate + Nystatin + Thiostrepton + Triamcinolone Acetonide | 997 | 150 |
| Neomycin Sulfate + Tetracaine Hydrochloride | 111 | 21 |
A report can name more than one set, so the counts of the sets can add to more than the count of the page.
An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another.
FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices
Signs that the reports list
A sign is a coded term from the report. The words in brackets are a plain gloss of the term. The percentage is the share of the 2,653 reports that list the sign. One report can list more than one sign and more than one drug.
The sign that is in the largest number of the reports comes first.
- Deafness12.8%340 reports
- Lethargy[unusually tired or inactive]12.8%340 reports
- Vomiting9.6%255 reports
- Lack of efficacy - NOS[the product did not have the expected effect]5.7%150 reports
- Diarrhoea[diarrhea]4.8%127 reports
- Anorexia[not eating]4.6%122 reports
- Elevated alanine aminotransferase (ALT)[a liver enzyme above the normal range]4.4%118 reports
- Other abnormal test result NOS[abnormal laboratory result, type not specified]4.1%110 reports
- Not eating4.1%108 reports
- Loss of hearing4%105 reports
- Death by euthanasia[the animal was euthanized]3.8%101 reports
- Behavioural disorder NOS[behaviour change, type not specified]3.4%91 reports
- Weight loss3.4%90 reports
- Ataxia[unsteady, uncoordinated movement]3.2%86 reports
Show the next 16 signs
- Decreased appetite3%80 reports
- Death2.9%76 reports
- Polydipsia[drinking more than usual]2.8%75 reports
- Seizure NOS[seizure, type not specified]2.7%72 reports
- Polyuria[passing more urine than usual]2.5%67 reports
- Vials, Damaged[a product quality report, not a sign in an animal]2.5%67 reports
- Skin lesion NOS[NOS: not otherwise specified]2.5%65 reports
- Neutrophilia[high neutrophil count]2.3%60 reports
- Pruritus[itching]2.2%59 reports
- Fever2.2%58 reports
- Accidental exposure[exposure that was not intended]2.1%57 reports
- Emesis[vomiting]2.1%56 reports
- Temporary deafness2.1%56 reports
- Elevated serum alkaline phosphatase (SAP)[a liver and bone enzyme above the normal range]2%54 reports
- Elevated total bilirubin[bilirubin above the normal range]2%54 reports
- Hyperglycaemia[high blood sugar]1.9%50 reports
Reports by species
Reports for each month, Jul 2021 to Jun 2026
No chart: no month has 5 or more reports.
The month is the month in which FDA received the report. Each chart has its own scale. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.
Reports by year
- Dog
- Cat
- Horse
- Other or not given
| Year | Dog | Cat | Horse | Other or not given | All species |
|---|---|---|---|---|---|
| 2026 | 72 | 75 | 0 | 35 | 182 |
| 2025 | 150 | 141 | 0 | 25 | 316 |
| 2024 | 115 | 92 | 0 | 27 | 234 |
| 2023 | 80 | 57 | 1 | 32 | 170 |
| 2022 | 63 | 68 | 0 | 33 | 164 |
| 2021 | 93 | 61 | 0 | 22 | 176 |
| 2020 | 121 | 51 | 0 | 31 | 203 |
| 2019 | 90 | 63 | 0 | 37 | 190 |
| 2018 | 99 | 51 | 0 | 42 | 192 |
| 2017 | 67 | 35 | 0 | 19 | 121 |
| 2016 | 83 | 24 | 0 | 15 | 122 |
| 2015 | 56 | 17 | 0 | 1 | 74 |
| 2014 | 35 | 18 | 0 | 4 | 57 |
| 2013 | 62 | 18 | 0 | 5 | 85 |
| 2012 | 62 | 15 | 1 | 14 | 92 |
| 2011 | 21 | 2 | 0 | 5 | 28 |
| 2010 | 10 | 2 | 0 | 4 | 16 |
| 2009 | 23 | 5 | 0 | 2 | 30 |
| 2008 | 7 | 3 | 0 | 4 | 14 |
| 2007 | 6 | 2 | 0 | 3 | 11 |
| 2006 | 4 | 1 | 0 | 4 | 9 |
| 2005 | 5 | 2 | 0 | 5 | 12 |
| 2004 | 6 | 0 | 0 | 2 | 8 |
| 2003 | 6 | 0 | 0 | 3 | 9 |
| 2002 | 4 | 0 | 0 | 5 | 9 |
| 2001 | 7 | 1 | 0 | 8 | 16 |
| 2000 | 6 | 0 | 0 | 5 | 11 |
| 1999 | 5 | 1 | 0 | 9 | 15 |
| 1998 | 9 | 0 | 0 | 1 | 10 |
| 1997 | 7 | 0 | 0 | 0 | 7 |
| 1996 | 7 | 3 | 0 | 0 | 10 |
| 1995 | 9 | 3 | 0 | 1 | 13 |
| 1994 | 15 | 0 | 0 | 0 | 15 |
| 1993 | 15 | 1 | 0 | 0 | 16 |
| 1992 | 6 | 0 | 0 | 0 | 6 |
| 1991 | 6 | 0 | 0 | 0 | 6 |
| 1990 | 2 | 0 | 0 | 0 | 2 |
| 1989 | 1 | 0 | 0 | 0 | 1 |
| 1988 | 0 | 1 | 0 | 0 | 1 |
2026 has the reports that FDA received through Jun 2026. Download the years (CSV)
What the reports record
Outcome at the time of the report
- Recovered/Normal16%425
- Recovered with Sequela[recovered, with a lasting effect]2.7%71
- Ongoing21.8%578
- Died3.7%98
- Euthanized3.7%97
- Outcome Unknown31.4%832
An outcome in a report is not proof that the drug caused it. The person who sends the report gives the outcome. Each share is of the 2,653 reports that name neomycin sulfate.
Kind of report
- Safety issue80.7%2,141
- Lack of expected effectiveness3.2%86
- Both safety and lack of expected effectiveness4.3%114
- Manufacturing or product defect11.6%307
- Other0.2%5
Age of the animal
- Under 1 year7.8%207
- 1 to 3 years14.1%373
- 4 to 7 years16.7%443
- 8 to 11 years21.5%571
- 12 years and over21.6%574
- Age not given18.3%485
Each share of kind and age is of the 2,653 reports that name neomycin sulfate.
Approved animal drugs with this active ingredient (FDA Green Book)
This section is reference data. It has no report count.
The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.
Brand names
- Neo-Cortef
- Neo-Delta-Cortef with Tetracaine
- Biosol
- Panolog
- Jenomycin
- Neo-synalar
- Neo-Predef with Tetracaine
- Tritop
- Neo-Darbazine Spansule
- Neo
- Anaprime
- Tresaderm Dermatologic
The Green Book has 16 more brand names with this active ingredient. Brand names A to Z
What the Green Book records give
- Applications with an approval in force
- 42
- Approved species
- Dogs, Cats, Cattle, Sheep, Swine, Goats, Turkeys, Chickens, Equids
- Dose forms
- Ointment, Liquid (Solution), Type A Medicated Article, Cream, Liquid, Liquid (Suspension), Powder for oral solution, Soluble Powder, Sustained Release Capsule, Powder, Powder for oral suspension, Solution, Tablet
- Routes
- Oral, Ophthalmic, Topical, Intramuscular, Intravenous
- Sale
- RX (prescription), VFD (veterinary feed directive), OTC (over the counter)
- Earliest approval date in the records
The species, dose forms and routes are the words of the Green Book records for all the applications together. One product can have fewer. The label of a product gives its approved use.
| Brand name | Active ingredients | Sponsor | Approved species | Application |
|---|---|---|---|---|
| Neo-Cortef with Tetracaine | Hydrocortisone Acetate, Neomycin Sulfate, Tetracaine Hydrochloride | Zoetis Inc. | Dogs, Cats | NADA 010-524 |
| Neomix 325 Soluble Powder; Neomix AG 325 Soluble Powder | Neomycin Sulfate | Phibro Animal Health Corp. | Cattle, Swine, Turkeys, Sheep, Goats | NADA 011-315 |
| Neo-Delta-Cortef with Tetracaine Ointment | Neomycin Sulfate, Prednisolone Acetate, Tetracaine Hydrochloride | Zoetis Inc. | Dogs, Cats | NADA 011-703 |
| Biosol Sterile Solution; Biosol Sterile Solution 50 mg | Neomycin Sulfate | Zoetis Inc. | Dogs, Cats | NADA 011-953 |
| Panolog Ointment | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Zoetis Inc. | Dogs, Cats | NADA 012-258 |
| Jenomycin Tablets | Aminopropazine Fumarate, Neomycin Sulfate | Intervet, Inc. | Dogs | NADA 013-181 |
| Neo-synalar Cream | Fluocinolone Acetonide, Neomycin Sulfate | Bausch Health US, LLC | Dogs, Cats | NADA 015-151 |
| Neo-Predef with Tetracaine Powder | Isoflupredone Acetate, Neomycin Sulfate, Tetracaine Hydrochloride | Zoetis Inc. | Dogs, Cats, Horses | NADA 015-433 |
| Neo-Predef with Tetracaine Top. Ointment; Tritop Topical Ointment | Isoflupredone Acetate, Neomycin Sulfate, Tetracaine Hydrochloride | Zoetis Inc. | Dogs, Cats, Horses | NADA 030-025 |
| Neo-Darbazine Spansule Capsule No.1; Neo-Darbazine Spansule Capsule No.3 | Isopropamide Iodide, Neomycin Sulfate, Prochlorperazine Dimaleate | Zoetis Inc. | Dogs | NADA 031-914 |
| Neo Predef Sterile Ointment | Isoflupredone Acetate, Neomycin Sulfate | Zoetis Inc. | Dogs, Cats, Horses, Cattle | NADA 034-872 |
| Anaprime Ophthalmic Solution | Flumethasone, Neomycin Sulfate, Polymyxin B Sulfate | Zoetis Inc. | Dogs, Cats | NADA 038-801 |
| Tresaderm Dermatologic Solution | Dexamethasone, Neomycin Sulfate, Thiabendazole | Boehringer Ingelheim Animal Health USA, Inc. | Dogs, Cats | NADA 042-633 |
| Anaprime Opthakote Ophthalmic | Flumethasone, Neomycin Sulfate, Polymyxin B Sulfate | Zoetis Inc. | Dogs | NADA 049-725 |
| Optiprime Opthakote Ophthalmic Solution | Neomycin Sulfate, Polymyxin B Sulfate | Zoetis Inc. | Dogs | NADA 049-726 |
| Bacitracin-Neomycin-Polymyxin with Hydrocortisone Acetate Ophthalmic Ointment; Vetropolycin HC Ophthalmic Ointment | Bacitracin Zinc, Hydrocortisone Acetate, Neomycin Sulfate, Polymyxin B Sulfate | Dechra Veterinary Products LLC | Dogs, Cats | NADA 065-015 |
| Bac-Neo-Poly Ophthalmic Ointment; Vetropolycin Ophthalmic Ointment | Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate | Dechra Veterinary Products LLC | Dogs, Cats | NADA 065-016 |
| Mycitracin Sterile Ophthalmic Ointment | Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate | Zoetis Inc. | Dogs, Cats | NADA 065-114 |
| Forte Topical Ointment | Hydrocortisone Acetate, Neomycin Sulfate, Penicillin G Procaine, Polymyxin B Sulfate | Zoetis Inc. | Dogs, Cats | NADA 065-119 |
| Cortisporin Veterinary Ophthalmic Ointment | Bacitracin Zinc, Hydrocortisone, Neomycin Sulfate, Polymyxin B Sulfate | Intervet, Inc. | Dogs, Cats | NADA 065-476 |
| Neosporin Ophthalmic Ointment | Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate | Intervet, Inc. | Dogs, Cats | NADA 065-485 |
| Neo-Delta Cortef Sterile Solution | Neomycin Sulfate, Prednisolone Acetate | Zoetis Inc. | Dogs, Cats | NADA 091-534 |
| Neo-Cortef Sterile Ointment | Hydrocortisone Acetate, Neomycin Sulfate | Zoetis Inc. | Dogs, Cats | NADA 093-514 |
| Neo-Terramycin 100/100; Neo-Terramycin 100/100D; Neo-Terramycin 50/50; Neo-Terramycin 50/50D | Neomycin Sulfate, Oxytetracycline | Phibro Animal Health Corp. | Cattle, Swine, Chickens, Turkeys, Sheep | NADA 094-975 |
| Panolog Cream | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Zoetis Inc. | Dogs, Cats | NADA 096-676 |
| Neo-Oxy 100/100 MR; Neo-Oxy 50/50 | Neomycin Sulfate, Oxytetracycline Hydrochloride | Pharmgate Inc. | Cattle, Swine, Chickens, Turkeys, Sheep | NADA 138-939 |
| Animax Ointment | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Fougera Pharmaceuticals, LLC | Dogs, Cats | NADA 140-847 |
| Derma 4 Ointment | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Zoetis Inc. | Dogs, Cats | NADA 140-879 |
| Neomix Ag 325; Neomix 325 | Neomycin Sulfate | Phibro Animal Health Corp. | Cattle, Swine, Sheep, Goats | NADA 140-976 |
| Derm-Otic Ointment | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Zoetis Inc. | Dogs, Cats | NADA 141-003 |
| Neomycin Sulfate | Neomycin Sulfate | Phibro Animal Health Corp. | Cattle, Swine, Sheep, Goats | ANADA 200-046 |
| NeoMed Soluble Powder | Neomycin Sulfate | Bimeda Animal Health Ltd. | Cattle, Swine, Turkeys, Sheep, Goats | ANADA 200-050 |
| Biosol Liquid | Neomycin Sulfate | Zoetis Inc. | Cattle, Swine, Sheep, Goats | ANADA 200-113 |
| Neomycin Oral Solution | Neomycin Sulfate | Huvepharma EOOD | Cattle, Swine, Sheep, Goats | ANADA 200-118 |
| Neo-Sol 50 | Neomycin Sulfate | Huvepharma EOOD | Cattle, Swine, Turkeys, Sheep, Goats | ANADA 200-130 |
| Neo 200 Oral Solution | Neomycin Sulfate | Huvepharma EOOD | Cattle, Swine, Sheep, Goats | ANADA 200-153 |
| Neosol Soluble Powder | Neomycin Sulfate | Dechra Veterinary Products LLC | Cattle, Swine, Sheep, Goats | ANADA 200-235 |
| Animax Cream | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Fougera Pharmaceuticals, LLC | Dogs, Cats | ANADA 200-330 |
| Neomycin Sulfate 325 | Neomycin Sulfate | Sparhawk Laboratories, Inc. | Cattle, Swine, Turkeys, Sheep, Goats | ANADA 200-378 |
| Neomycin Liquid | Neomycin Sulfate | Sparhawk Laboratories, Inc. | Cattle, Swine, Sheep, Goats | ANADA 200-379 |
| Neomycin and Polymyxin B Sulfates, and Bacitracin Zinc Ophthalmic Ointment | Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate | Domes Pharma S.A. | Dogs, Cats | ANADA 200-553 |
| Thiabendazole, Dexamethasone, Neomycin Sulfate Solution | Dexamethasone, Neomycin Sulfate, Thiabendazole | Dechra Veterinary Products LLC | Dogs, Cats | ANADA 200-565 |
| Hydeltrone Ointmentapproval withdrawn | Neomycin Sulfate, Prednisolone Sodium Phosphate | Boehringer Ingelheim Animal Health USA Inc. | Dogs, Cats | NADA 011-437 |
| Neo-Aristovet Ointmentapproval withdrawn | Neomycin Sulfate, Triamcinolone Acetonide | Bayer HealthCare LLC, Animal Health Division | Not in the list of major species | NADA 030-045 |
| Tylan Plus Neomycin Eye Powderapproval withdrawn | Neomycin Sulfate, Tylosin | Elanco Animal Health, A Division of Eli Lilly & Co. | Not in the list of major species | NADA 031-962 |
| Liquisone F with Cerumeneapproval withdrawn | Hexamethyltetracosane, Neomycin Sulfate, Prednisolone, Tetracaine | Evsco Pharmaceuticals, An Affiliate of IGI, Inc. | Dogs, Cats | NADA 032-322 |
| Neomycane Ophthalmic Ointmentapproval withdrawn | Neomycin Sulfate | Evsco Pharmaceuticals, An Affiliate of IGI, Inc. | Dogs, Cats | NADA 044-655 |
| Optisoneapproval withdrawn | Neomycin Sulfate, Prednisolone Acetate | Evsco Pharmaceuticals, An Affiliate of IGI, Inc. | Dogs, Cats | NADA 045-288 |
| DERMA-VET Ointmentapproval withdrawn | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Med-Pharmex, Inc. | Dogs, Cats | NADA 140-810 |
| Derm-Otic Ointmentapproval withdrawn | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Biocraft Laboratories, Inc. | Dogs, Cats | NADA 140-889 |
| Derma-Vet Creamapproval withdrawn | Neomycin Sulfate, Nystatin, Thiostrepton, Triamcinolone Acetonide | Med-Pharmex, Inc. | Dogs, Cats | ANADA 200-245 |
| Neosol-Oralapproval withdrawn | Neomycin Sulfate | Med-Pharmex, Inc. | Cattle, Swine, Turkeys, Sheep, Goats | ANADA 200-289 |
FDA pages for this ingredient
- How to Report Animal Drug and Device Side Effects and Product ProblemsThe FDA page that tells an owner or a veterinarian how to send a report.
- Green Book record of NADA 010-524The FDA record of the application for Neo-Cortef with Tetracaine.
- Green Book record of NADA 011-703The FDA record of the application for Neo-Delta-Cortef with Tetracaine Ointment.
- Green Book record of NADA 011-953The FDA record of the application for Biosol Sterile Solution, Biosol Sterile Solution 50 mg.
- Green Book record of NADA 012-258The FDA record of the application for Panolog Ointment.
- Green Book record of NADA 013-181The FDA record of the application for Jenomycin Tablets.
- Green Book record of NADA 015-151The FDA record of the application for Neo-synalar Cream.
- Animal Drugs @ FDAThe search page of the Green Book, the FDA list of approved animal drugs.
The site checked these addresses on . The links open in a new tab.
Cite this page
Pet Drug Reports. Neomycin Sulfate, all combinations: adverse event reports that FDA received. https://petdrugreports.com/ingredient/neomycin-sulfate/ Source: FDA Center for Veterinary Medicine, openFDA Animal and Veterinary adverse event reports, export of . Reports received through .
Where the data come from
The counts come from the openFDA Animal and Veterinary adverse event files, export of 30 Oct 2026. The files have the reports that the FDA Center for Veterinary Medicine received through 26 Jun 2026. The files mask brand and manufacturer names. The site counts a drug by the active ingredients that each record gives, and gives no count to a brand, an application or a company. Ingredient names and the lists of approved products follow the FDA Green Book of 2 Nov 2026. Ingredient names follow the Green Book, with salts and forms as FDA lists them.
The site does not publish report text, lot numbers or details of a reporter. FDA's record is the authority. See how the site counts reports, the data sources and the corrections page.
Questions about these reports
- Which brand are these reports about?
The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand. The Green Book section of this page lists brand names with this active ingredient.
- Do the reports show that the ingredient caused the signs?
No. A report can name more than one drug, and a drug can have more than one active ingredient. FDA states this about the data.
When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event.
The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.
FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices
- How many reports did FDA receive in the latest 12 months?
FDA received 359 reports in the 12 months to June 2026. It received 273 reports in the 12 months before. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.
- What kinds of report are in the count?
Of the 2,653 reports received from September 1988 to June 2026, 80.7% are about a safety issue only. 7.5% are about a lack of expected effectiveness, alone or with a safety issue. 11.6% are about a defect of the product or its package.